期刊
EXPERT OPINION ON INVESTIGATIONAL DRUGS
卷 17, 期 3, 页码 263-267出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543784.17.3.263
关键词
diet; drug therapy; lifestyle; obesity; weight loss
Background: Obesity causes serious medical complications and impairs quality of life. However, its management remains challenging. Objective: To assist health professionals who counsel patients who are overweight or obese by discussing the possible add-on value of new drugs over lifestyle interventions. Methods: A critical analysis is made of the available evidence of the long-term efficacy of diet and exercise and/or anti-obesity agents such as orlistat, sibutramine and rimonabant. Results/conclusion: Lifestyle interventions remain the cornerstone of the treatment of obesity, but adherence is poor and long-term success is modest. Pharmacological agents may be useful adjuncts for improving weight loss and maintenance, and health outcomes, and should be continued in good responders. Drug therapy and lifestyle intervention are not opponent strategies, but should probably be combined to tackle obesity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据